Nobody can see the future. But will the future help us see better?
It is a question that feels particularly relevant to ophthalmology, a specialty that has always stood at the intersection of science, technology and the most fundamental human sense—vision.
The next decade will fundamentally redefine how we see, diagnose and treat eye disease in India. Artificial intelligence will increasingly assist clinical decisions, portable technologies will take diagnostics beyond hospital walls, personalised medicine will influence treatment choices, and advances in retinal and lens technology will redefine what patients expect from their vision.
But India’s greatest challenge and opportunity will be to ensure that this technological revolution does not remain accessible only to a privileged few.
With one of the world’s largest and most diverse populations, India carries a unique burden of eye disease, ranging from cataract and diabetic retinopathy to glaucoma, childhood blindness and the rapidly emerging epidemic of myopia. Over the next decade, the future of Indian ophthalmology will therefore be shaped by two parallel forces: extraordinary technological innovation and the urgent need to democratise access to quality eye care.
Artificial intelligence (AI) will move from the laboratory into everyday clinical practice. AI-assisted analysis of retinal photographs and OCT scans is already changing the way we detect diabetic retinopathy, glaucoma and retinal diseases. Over the coming decade, AI is likely to become an important clinical assistant—helping with screening, diagnosis, risk prediction and monitoring treatment response. It may also support cataract grading, IOL power calculations and surgical training.
“AI may become the ophthalmologist’s most powerful assistant, but it will never replace the clinical judgement, empathy and human connection at the heart of patient care.”
The goal should not be to replace the ophthalmologist, but to augment human expertise and allow doctors to focus more on complex decision-making and patient care.
Teleophthalmology and decentralised care will become increasingly important. India cannot depend solely on tertiary eye hospitals to address its enormous burden of avoidable blindness.
Smartphone-based imaging, portable diagnostic devices and teleconsultation can bring screening closer to patients in rural and underserved regions. The next step will be to build robust referral networks so that a patient identified remotely can seamlessly reach the right specialist when required.
Cataract surgery will evolve from restoring sight to optimising visual quality. India will continue to face a significant cataract burden, but the expectations of patients are changing. Advances in biometry, IOL technology, image-guided surgery and personalised lens selection will increasingly allow us to tailor outcomes to individual lifestyles. Premium and enhanced-depth-of-focus lenses, toric IOLs and increasingly sophisticated calculations will expand the possibilities of spectacle independence.
At the same time, the real challenge will remain ensuring that high-quality cataract surgery reaches every section of society—not only those who can afford premium technology.
Retinal care is likely to undergo a therapeutic revolution. The future may see a shift from frequent injections towards longer-acting drug delivery systems, sustained-release therapies and treatments designed around individual disease biology. Advances in genetics and gene-based therapies are opening new possibilities for inherited retinal disorders, while AI and multimodal imaging may help identify disease earlier and predict which patients are most likely to respond to specific treatments.
Myopia will emerge as one of the defining public-health challenges of the next decade. As lifestyles change and children spend less time outdoors, the rising prevalence of childhood myopia will require a shift from simply correcting refractive error to actively preventing disease progression. Early screening, school-based programmes, increased outdoor activity and evidence-based myopia-control strategies will become increasingly important components of paediatric eye care.
Precision medicine will gradually enter ophthalmology. The future will be less about treating every patient with the same disease in exactly the same way and more about understanding individual risk, genetics, imaging biomarkers and treatment response. This approach could influence everything from glaucoma monitoring and retinal therapeutics to personalised IOL selection.
Ultimately, the most important trend may be the democratisation of eye care. India’s future success will not be measured simply by how advanced our technology becomes, but by how many people can actually benefit from it. We will need investment in trained manpower, primary eye-care networks, quality standards, digital infrastructure and affordable treatment pathways.
“The future of Indian ophthalmology will not be defined by technology alone, but by our ability to make that technology accessible to every patient who needs it.”
The ophthalmologist of 2035 will therefore be part clinician, part technologist and part public-health professional. Yet, despite all the advances, one principle will remain unchanged: technology may transform how we practise ophthalmology, but it is the human connection that will continue to define how we care for our patients.
And perhaps that brings us back to the question with which we began:
Nobody can see the future. But if we get the future of eye care right, perhaps it will help millions of Indians see a better one.